Stanozolol (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Stanozolol" in Czech language version.

refsWebsite
Global rank Czech rank
3rd place
25th place
4th place
8th place
2nd place
4th place
447th place
753rd place
6th place
10th place
1st place
1st place
399th place
1,058th place
259th place
939th place
3,325th place
low place
1,349th place
2,132nd place
22nd place
144th place
2,474th place
low place
low place
low place
low place
low place

archive.org

  • Oznámení úřadu pro potraviny a léky. "DESI 7630. Určité anabolické steroidy, drogy pro humánní použití: implementace studie účinnosti léku" Federální rejstřík č. 35, č. 122. 24. června 1970 . str. 10327-28
  • Oznámení úřadu pro potraviny a léky. Docket č. 80N-0276; DESI 7630. Tablety Winstrol; Drogy pro lidské použití; Provádění studie účinnosti léčiv, zrušení výjimky; Oznámení o následných opatřeních a příležitost pro slyšení o návrhu na odvolání schválení nového registru léků , 23. dubna 1984 . str. 17094-99

books.google.com

  • Index Nominum 2000: International Drug Directory. [s.l.]: Taylor & Francis, 2000. Dostupné online. ISBN 978-3-88763-075-1. S. 961–. 
  • William Llewellyn. Anabolics. [s.l.]: Molecular Nutrition Llc, 2011. Dostupné online. ISBN 978-0-9828280-1-4. S. 726–737. 
  • Henri N. Doods. Receptor Data for Biological Experiments: A Guide to Drug Selectivity. [s.l.]: Ellis Horwood, 1991. Dostupné online. ISBN 978-0-13-767450-3. S. 250. 
  • John P. Bilezikian; LAWRENCE G. RAISZ; GIDEON A. RODAN. Principles of Bone Biology, Two-Volume Set. [s.l.]: Academic Press, 19 January 2002. Dostupné online. ISBN 978-0-08-053960-7. S. 1455–. 
  • Abigail Herron; TIMOTHY K. BRENNAN. The ASAM Essentials of Addiction Medicine. [s.l.]: Wolters Kluwer Health, 18 March 2015. Dostupné online. ISBN 978-1-4963-1067-5. S. 262–. 
  • Detlef Thieme; PETER HEMMERSBACH. Doping in Sports. [s.l.]: Springer Science & Business Media, 18 December 2009. Dostupné online. ISBN 978-3-540-79088-4. S. 166–. 
  • William Andrew Publishing. Pharmaceutical Manufacturing Encyclopedia. [s.l.]: Elsevier, 22 October 2013. Dostupné online. ISBN 978-0-8155-1856-3. S. 3067–. 

doi.org

dx.doi.org

  • KICMAN, A T. Pharmacology of anabolic steroids. British Journal of Pharmacology. 2008, s. 502–521. DOI 10.1038/bjp.2008.165. PMID 18500378. 
  • Saartok T, Dahlberg E, Gustafsson JA. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology. 1984, s. 2100–6. DOI 10.1210/endo-114-6-2100. PMID 6539197. 
  • Mateus-Avois L, Mangin P, Saugy M. Use of ion trap gas chromatography-multiple mass spectrometry for the detection and confirmation of 3'hydroxystanozolol at trace levels in urine for doping control. Journal of Chromatography B. 2005, s. 193–201. DOI 10.1016/j.jchromb.2004.11.033. PMID 15664350. 
  • Pozo OJ, Van Eenoo P, Deventer K, Lootens L, Grimalt S, Sancho JV, Hernández F, Meuleman P, Leroux-Roels G, Delbeke FT. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry. Steroids. 2009, s. 837–52. DOI 10.1016/j.steroids.2009.05.004. PMID 19464304. 

drugs.com

  • Stanozolol - Drugs.com [online]. Dostupné online. 

fda.gov

accessdata.fda.gov

fda.gov

federalregister.gov

haea.org

illinois.edu

scs.illinois.edu

latimes.com

articles.latimes.com

  • Kodak to Sell Drug Unit for $1.68 Billion. Los Angeles Times. June 24, 1994. Dostupné online [cit. 3 May 2013]. 

medscape.org

nasonline.org

nih.gov

ncbi.nlm.nih.gov

  • BURNAND, K; CLEMENSON, G; MORLAND, M; JARRETT, PE; BROWSE, NL. Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression.. British Medical Journal. 5 January 1980, s. 7–11. PMID 6986945. 
  • MCMULLIN, GM; WATKIN, GT; COLERIDGE SMITH, PD; SCURR, JH. Efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency.. The Australian and New Zealand Journal of Surgery. April 1991, s. 306–9. PMID 2018441. 
  • KICMAN, A T. Pharmacology of anabolic steroids. British Journal of Pharmacology. 2008, s. 502–521. DOI 10.1038/bjp.2008.165. PMID 18500378. 
  • Saartok T, Dahlberg E, Gustafsson JA. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology. 1984, s. 2100–6. DOI 10.1210/endo-114-6-2100. PMID 6539197. 
  • Mateus-Avois L, Mangin P, Saugy M. Use of ion trap gas chromatography-multiple mass spectrometry for the detection and confirmation of 3'hydroxystanozolol at trace levels in urine for doping control. Journal of Chromatography B. 2005, s. 193–201. DOI 10.1016/j.jchromb.2004.11.033. PMID 15664350. 
  • Pozo OJ, Van Eenoo P, Deventer K, Lootens L, Grimalt S, Sancho JV, Hernández F, Meuleman P, Leroux-Roels G, Delbeke FT. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry. Steroids. 2009, s. 837–52. DOI 10.1016/j.steroids.2009.05.004. PMID 19464304. 
  • Levin J, Trafford JA, Bishop PM. Stanozolol, a new anabolic steroid. J New Drugs. 1962 Jan-Feb;2:50-5. PMID 14464563

slate.com

web.archive.org